CICCARELLI, NICOLETTA
 Distribuzione geografica
Continente #
EU - Europa 1.606
NA - Nord America 322
AS - Asia 163
SA - Sud America 20
AF - Africa 3
OC - Oceania 2
Totale 2.116
Nazione #
RU - Federazione Russa 1.416
US - Stati Uniti d'America 316
SG - Singapore 133
IT - Italia 100
DE - Germania 23
BR - Brasile 19
FR - Francia 17
GB - Regno Unito 14
AT - Austria 10
IN - India 9
FI - Finlandia 8
HK - Hong Kong 8
IE - Irlanda 7
NL - Olanda 5
CA - Canada 3
IL - Israele 3
AU - Australia 2
MX - Messico 2
PL - Polonia 2
TR - Turchia 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
SE - Svezia 1
TM - Turkmenistan 1
UA - Ucraina 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.116
Città #
Moscow 131
Singapore 85
Santa Clara 58
The Dalles 53
Chicago 46
Castelgomberto 38
Rome 23
Secaucus 20
Buffalo 16
Elk Grove Village 16
Assago 14
Yubileyny 13
Lauterbourg 12
Los Angeles 11
Portsmouth 9
Dublin 8
Helsinki 8
Nuremberg 8
Hong Kong 7
Mumbai 6
Milan 5
Pasadena 5
Ashburn 4
Cagliari 4
Salerno 4
São Paulo 3
Atlanta 2
Boston 2
Boydton 2
Cologno Monzese 2
Como 2
Düsseldorf 2
Indianapolis 2
New Delhi 2
New York 2
Vienna 2
Warsaw 2
Wembley 2
West Jordan 2
Ashgabat 1
Balneário Gaivota 1
Bauru 1
Belo Horizonte 1
Bexley 1
Bountiful 1
Brescia 1
Brooklyn 1
Cairo 1
Calgary 1
Can Tho 1
Clarksburg 1
Cuiabá 1
Dallas 1
Garfield 1
Greensboro 1
Greenville 1
Ho Chi Minh City 1
Itaquaquecetuba 1
Izmail 1
Joaquim Távora 1
Karachi 1
Kingston 1
Kulgam 1
Lerdo 1
Liberty Lake 1
London 1
Magnolia 1
Manaus 1
Maracay 1
Merced 1
Mexico City 1
Montreal 1
Oxnard 1
Pardinho 1
Pastos Bons 1
Pavia 1
Phoenix 1
Pinheiro 1
Pomerode 1
Prague 1
Praia Grande 1
Rishon LeTsiyyon 1
Riyadh 1
Rock Falls 1
San Francisco 1
San Jose 1
Santo Antônio do Descoberto 1
Smyrna 1
Stockholm 1
Sydney 1
Tallinn 1
Tampa 1
Teixeira de Freitas 1
Tokyo 1
Unaí 1
Washington 1
Yalova 1
Yerres 1
Yonkers 1
Totale 693
Nome #
Degenerative and Vascular Fluent Aphasia: Looking for Differences 75
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 73
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients 73
Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population 71
Cognitive reserve and neuropsychological functioning in older HIV-infected people 68
Cognitive reserve: a multidimensional protective factor in Parkinson’s disease related cognitive impairment 64
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 60
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 59
Efficacy and safety of treatment simplification to atazanavir/ritonavir1lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 58
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 58
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients 57
Differences in the Long-term Impact of the COVID-19 Pandemic on the Mental Health and Professional Quality of Life of Resident and Specialist Physicians 56
Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update? 56
Emotional valence may influence memory performance for visual artworks in Parkinson’s disease 54
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 53
The facial emotion recognition deficit in Parkinson’s disease: Implications of a visual scanning strategy 53
Baseline CD4+ T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 52
Safety and feasibility of treatment simplification to atazanavir/ ritonavir1lamivudine in hiv-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors1atazanavir/ ritonavir with virological suppression (atazanavir and lamivudine for treatment simplification, atlas pilot study) 49
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 48
Naming of grammatical classes in frontotemporal dementias: Linguistic and non linguistic factors contribute to noun-verb dissociation 47
Effect of aging and human immunodeficiency virus infection on cognitive abilities 47
Posterior AD-Type pathology: Cognitive subtypes emerging from a cluster analysis 46
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 45
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 45
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 44
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 44
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 43
Psychological distress during the initial stage of the COVID-19 pandemic in an Italian population living with HIV: an online survey 43
Primary progressive aphasia: Linguistic patterns and clinical variants 42
The deficit for the word-class "verb" in corticobasal degeneration: Linguistic expression of the movement disorder? 42
The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease 41
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 41
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer’s disease, and Parkinson’s disease: An evaluation of the “cortical hypothesis” of NeuroAIDS 40
Unilateral Spatial Neglect in Degenerative Brain Pathology 40
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 39
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 38
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 38
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 38
Semantic memory in object use 37
Writing errors in primary progressive aphasia 36
Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients 35
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 35
Revised central nervous system neuropenetrationeffectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 34
Liver fibrosis is associated with cognitive impairment in people living with HIV 33
Early neuropsychological screening and long-term functional outcome in a sample of patients affected by mild stroke: The ReSCog Project 8
Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial 6
Sleep Disorders Are Associated with Mental Health, Quality of Life and Stigma in an Italian Cohort of People Living with HIV 3
Totale 2.167
Categoria #
all - tutte 10.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.531


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20244 0 0 0 0 0 0 0 0 1 2 0 1
2024/20252.128 1 2 171 17 59 155 1.068 357 104 37 38 119
2025/202635 35 0 0 0 0 0 0 0 0 0 0 0
Totale 2.167